Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Biodiversity conservation and drug discovery: Can they be combined? The Suriname and Madagascar experiences.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Cao, Shugeng1 (AUTHOR); Kingston, David G. I.1 (AUTHOR)
- Source:
Pharmaceutical Biology. Aug2009, Vol. 47 Issue 8, p809-823. 15p. 11 Diagrams.
- Subject Terms:
- Additional Information
- Abstract:
The approach to new drugs through natural products has proved to be the single most successful strategy for the discovery of new drugs, but in recent years its use has been deemphasized by many pharmaceutical companies in favor of approaches based on combinatorial chemistry and genomics, among others. Drug discovery from natural sources requires continued access to plant, marine, and microbial biomass, and so the preservation of tropical rainforests is an important part of our drug discovery program. Sadly, many of the tropical forests of the world are under severe environmental pressure, and deforestation is a serious problem in most tropical countries. One way to combat this loss is to demonstrate their value as potential sources of new pharmaceutical or agrochemical products. As part of an effort to integrate biodiversity conservation and drug discovery with economic development, we initiated an International Cooperative Biodiversity Group (ICBG) to discover potential pharmaceuticals from the plant biodiversity of Suriname and Madagascar. The Group, established with funding from agencies of the United States government, involved participants from the USA, Suriname, and Madagascar. The basic approach was to search for bioactive plants in the Suriname and Malagasy flora, and to isolate their bioactive constituents by the best available methods, but the work included capacity building as well as research. Progress on this project is reported, drawing on results obtained from the isolation of bioactive natural products from Suriname and Madagascar. The benefits of this general approach to biodiversity and drug discovery are also discussed. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Pharmaceutical Biology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.